What is the market doing?
What the tape says about OCUL
Ocular Therapeutix, Inc. is −12% over the past year while the S&P 500 is +23%: 35 points behind the market. Through the fall, its own insiders bought $256K more stock than they sold.
−12%
1-year return · S&P 500 +23%
- vs 200-day average
- +6.9%
vs 200-day average · close to trend
- RSI (14)
- 73
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- −33%
Below its 52-week high
Details›
- Last close2026-08-26
- $10.77
- 1 monthS&P 500 +3.7%
- +25%
- 1 yearS&P 500 +23%
- −12%
- 5 yearsS&P 500 +87%
- −4.4%
- vs 50-day average$9.41
- +14%
- 52-week high
- $16.11
- 52-week low
- $6.88
- Annualised volatility
- 68%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- $256K
| Year | Return |
|---|---|
| 2026 (year to date) | −11% |
| 2025 | +42% |
| 2024 | +91% |
| 2023 | +59% |
| 2022 | −60% |
| 2021 | −66% |
| 2020 | +424% |
| 2019 | −0.75% |
| 2018 | −11% |
| 2017 | −47% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | −1.1% |
| Feb | 10 | 6 of 10 | +20% |
| Mar | 10 | 4 of 10 | −1.7% |
| Apr | 10 | 6 of 10 | −0.75% |
| May | 10 | 5 of 10 | −0.74% |
| Jun | 10 | 6 of 10 | +11% |
| Jul | 11 | 4 of 11 | −4.5% |
| Aug | 11 | 7 of 11 | +9.1% |
| Sep | 10 | 2 of 10 | −8.0% |
| Oct | 10 | 3 of 10 | −5.6% |
| Nov | 10 | 6 of 10 | +15% |
| Dec | 10 | 4 of 10 | +3.8% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.